Islet Amyloid Polypeptide

Structure, Function, and Pathophysiology

Rehana Akter, Ping Cao, Harris Noor, Zachary Ridgway, Ling-Hsien Tu, Hui Wang, Amy G. Wong, Xiaoxue Zhang, Andisheh Abedini, Ann Marie Schmidt, Daniel P. Raleigh

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The hormone islet amyloid polypeptide (IAPP, or amylin) plays a role in glucose homeostasis but aggregates to form islet amyloid in type-2 diabetes. Islet amyloid formation contributes to β-cell dysfunction and death in the disease and to the failure of islet transplants. Recent work suggests a role for IAPP aggregation in cardiovascular complications of type-2 diabetes and hints at a possible role in type-1 diabetes. The mechanisms of IAPP amyloid formation in vivo or in vitro are not understood and the mechanisms of IAPP induced β-cell death are not fully defined. Activation of the inflammasome, defects in autophagy, ER stress, generation of reactive oxygen species, membrane disruption, and receptor mediated mechanisms have all been proposed to play a role. Open questions in the field include the relative importance of the various mechanisms of β-cell death, the relevance of reductionist biophysical studies to the situation in vivo, the molecular mechanism of amyloid formation in vitro and in vivo, the factors which trigger amyloid formation in type-2 diabetes, the potential role of IAPP in type-1 diabetes, the development of clinically relevant inhibitors of islet amyloidosis toxicity, and the design of soluble, bioactive variants of IAPP for use as adjuncts to insulin therapy.

Original languageEnglish
Article number2798269
JournalJournal of Diabetes Research
Volume2016
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Islet Amyloid Polypeptide
Amyloid
Type 2 Diabetes Mellitus
Cell Death
Type 1 Diabetes Mellitus
Inflammasomes
Autophagy
Amyloidosis
Reactive Oxygen Species
Homeostasis
Hormones
Insulin
Transplants
Glucose
Membranes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L-H., Wang, H., ... Raleigh, D. P. (2016). Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology. Journal of Diabetes Research, 2016, [2798269]. https://doi.org/10.1155/2016/2798269

Islet Amyloid Polypeptide : Structure, Function, and Pathophysiology. / Akter, Rehana; Cao, Ping; Noor, Harris; Ridgway, Zachary; Tu, Ling-Hsien; Wang, Hui; Wong, Amy G.; Zhang, Xiaoxue; Abedini, Andisheh; Schmidt, Ann Marie; Raleigh, Daniel P.

In: Journal of Diabetes Research, Vol. 2016, 2798269, 01.01.2016.

Research output: Contribution to journalArticle

Akter, R, Cao, P, Noor, H, Ridgway, Z, Tu, L-H, Wang, H, Wong, AG, Zhang, X, Abedini, A, Schmidt, AM & Raleigh, DP 2016, 'Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology', Journal of Diabetes Research, vol. 2016, 2798269. https://doi.org/10.1155/2016/2798269
Akter, Rehana ; Cao, Ping ; Noor, Harris ; Ridgway, Zachary ; Tu, Ling-Hsien ; Wang, Hui ; Wong, Amy G. ; Zhang, Xiaoxue ; Abedini, Andisheh ; Schmidt, Ann Marie ; Raleigh, Daniel P. / Islet Amyloid Polypeptide : Structure, Function, and Pathophysiology. In: Journal of Diabetes Research. 2016 ; Vol. 2016.
@article{6dba4f269deb46acab9bac88c59fc815,
title = "Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology",
abstract = "The hormone islet amyloid polypeptide (IAPP, or amylin) plays a role in glucose homeostasis but aggregates to form islet amyloid in type-2 diabetes. Islet amyloid formation contributes to β-cell dysfunction and death in the disease and to the failure of islet transplants. Recent work suggests a role for IAPP aggregation in cardiovascular complications of type-2 diabetes and hints at a possible role in type-1 diabetes. The mechanisms of IAPP amyloid formation in vivo or in vitro are not understood and the mechanisms of IAPP induced β-cell death are not fully defined. Activation of the inflammasome, defects in autophagy, ER stress, generation of reactive oxygen species, membrane disruption, and receptor mediated mechanisms have all been proposed to play a role. Open questions in the field include the relative importance of the various mechanisms of β-cell death, the relevance of reductionist biophysical studies to the situation in vivo, the molecular mechanism of amyloid formation in vitro and in vivo, the factors which trigger amyloid formation in type-2 diabetes, the potential role of IAPP in type-1 diabetes, the development of clinically relevant inhibitors of islet amyloidosis toxicity, and the design of soluble, bioactive variants of IAPP for use as adjuncts to insulin therapy.",
author = "Rehana Akter and Ping Cao and Harris Noor and Zachary Ridgway and Ling-Hsien Tu and Hui Wang and Wong, {Amy G.} and Xiaoxue Zhang and Andisheh Abedini and Schmidt, {Ann Marie} and Raleigh, {Daniel P.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1155/2016/2798269",
language = "English",
volume = "2016",
journal = "Journal of Diabetes Research",
issn = "2314-6745",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Islet Amyloid Polypeptide

T2 - Structure, Function, and Pathophysiology

AU - Akter, Rehana

AU - Cao, Ping

AU - Noor, Harris

AU - Ridgway, Zachary

AU - Tu, Ling-Hsien

AU - Wang, Hui

AU - Wong, Amy G.

AU - Zhang, Xiaoxue

AU - Abedini, Andisheh

AU - Schmidt, Ann Marie

AU - Raleigh, Daniel P.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The hormone islet amyloid polypeptide (IAPP, or amylin) plays a role in glucose homeostasis but aggregates to form islet amyloid in type-2 diabetes. Islet amyloid formation contributes to β-cell dysfunction and death in the disease and to the failure of islet transplants. Recent work suggests a role for IAPP aggregation in cardiovascular complications of type-2 diabetes and hints at a possible role in type-1 diabetes. The mechanisms of IAPP amyloid formation in vivo or in vitro are not understood and the mechanisms of IAPP induced β-cell death are not fully defined. Activation of the inflammasome, defects in autophagy, ER stress, generation of reactive oxygen species, membrane disruption, and receptor mediated mechanisms have all been proposed to play a role. Open questions in the field include the relative importance of the various mechanisms of β-cell death, the relevance of reductionist biophysical studies to the situation in vivo, the molecular mechanism of amyloid formation in vitro and in vivo, the factors which trigger amyloid formation in type-2 diabetes, the potential role of IAPP in type-1 diabetes, the development of clinically relevant inhibitors of islet amyloidosis toxicity, and the design of soluble, bioactive variants of IAPP for use as adjuncts to insulin therapy.

AB - The hormone islet amyloid polypeptide (IAPP, or amylin) plays a role in glucose homeostasis but aggregates to form islet amyloid in type-2 diabetes. Islet amyloid formation contributes to β-cell dysfunction and death in the disease and to the failure of islet transplants. Recent work suggests a role for IAPP aggregation in cardiovascular complications of type-2 diabetes and hints at a possible role in type-1 diabetes. The mechanisms of IAPP amyloid formation in vivo or in vitro are not understood and the mechanisms of IAPP induced β-cell death are not fully defined. Activation of the inflammasome, defects in autophagy, ER stress, generation of reactive oxygen species, membrane disruption, and receptor mediated mechanisms have all been proposed to play a role. Open questions in the field include the relative importance of the various mechanisms of β-cell death, the relevance of reductionist biophysical studies to the situation in vivo, the molecular mechanism of amyloid formation in vitro and in vivo, the factors which trigger amyloid formation in type-2 diabetes, the potential role of IAPP in type-1 diabetes, the development of clinically relevant inhibitors of islet amyloidosis toxicity, and the design of soluble, bioactive variants of IAPP for use as adjuncts to insulin therapy.

UR - http://www.scopus.com/inward/record.url?scp=84948798570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948798570&partnerID=8YFLogxK

U2 - 10.1155/2016/2798269

DO - 10.1155/2016/2798269

M3 - Article

VL - 2016

JO - Journal of Diabetes Research

JF - Journal of Diabetes Research

SN - 2314-6745

M1 - 2798269

ER -